At a Glance
| Aniracetam | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 1200–1800 mg | 1000–2000 mg |
| Total Duration | 0.8–1.5 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects | 21 documented | 4 documented |
Aniracetam, a Nootropic, and D-Serine, a Nootropic, NMDA enhancer, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Aniracetam is classified as a Nootropic while D-Serine is a Nootropic, NMDA enhancer, meaning they approach altered states through different pharmacological mechanisms. They share 3 documented effects in common, with 18 effects unique to Aniracetam and 1 unique to D-Serine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Aniracetam | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 1200–1800 mg | 1000–2000 mg |
| Total Duration | 0.8–1.5 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects | 21 documented | 4 documented |
| Level | Aniracetam | D-Serine |
|---|---|---|
| Threshold | 350 mg | — mg |
| Light | 500–1200 mg | 500–1000 mg |
| Common | 1200–1800 mg | 1000–2000 mg |
| Strong | 1800–2400 mg | 2000–4000 mg |
| Heavy | 2400 mg | 8000 mg |
Aniracetam
D-Serine
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.